Sepsis-Induced Coagulopathy as a Risk for Postoperative Arterial Thrombosis: A Case Report

Background: Venous thromboembolic disease and arterial thrombosis are recognized as common causes of hospital mortality, especially in postoperative patients, those who are immobilized, and individuals with sepsis. Coagulopathy is a significant factor due to the interaction between inflammation and...

Full description

Saved in:
Bibliographic Details
Main Authors: Dewi Swastikasari, Septian Adi Permana
Format: Article
Language:English
Published: Fakultas Kedokteran, Universitas Diponegoro 2025-03-01
Series:JAI (Jurnal Anestesiologi Indonesia)
Subjects:
Online Access:https://ejournal.undip.ac.id/index.php/janesti/article/view/57473
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Venous thromboembolic disease and arterial thrombosis are recognized as common causes of hospital mortality, especially in postoperative patients, those who are immobilized, and individuals with sepsis. Coagulopathy is a significant factor due to the interaction between inflammation and coagulation, stemming from widespread endothelial damage. Case: We report manifestations of sepsis-induced coagulopathy (SIC) in a 64-year-old woman who was treated at the intensive care unit (ICU) of RSUD Dr. Moewardi with peripheral arterial disease. The patient was treated for 20 days in the ICU with a multidisciplinary approach. The patient's clinical outcome was good and planned for follow-up during outpatient care. Discussion: Thrombosis and inflammation are distinct yet closely interconnected physiological processes. In a normal physiological context, the activation of the coagulation system by inflammation is a component of the body's defense mechanism against pathogens, aiming to restrict their spread within the bloodstream. This protective response involves the interaction between innate immune cells and platelets. Conclusion: By gaining a deeper insight into sepsis-associated coagulopathy (microthrombopathy), we can develop effective treatments that specifically target the microthrombotic pathway involved in endothelial damage.
ISSN:2337-5124
2089-970X